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ABSTRACT
Background    Sepsis is a syndrome triggered by endo-
toxin lipopolysaccharide (LPS) during bacterial infec-
tion. Sepsis sometimes recurs, with the second sepsis 
giving rise to a different phenotype because of disease 
modification by the preceding sepsis. Such a protective 
modification is called a preconditioning (PC) effect. PC 
is an endogenous protective mechanism by which sub-
lethal damage confers tolerance to a subsequent lethal 
load. Oxidative stress is one of the important pathoge-
netic mechanisms that occur in sepsis. The nuclear fac-
tor erythroid 2 (NF-E2)-related factor-2 (Nrf2) system is 
a key regulatory transcription factor that protects organs 
and cells against oxidative stress and may be associated 
with the PC effect in repeated sepsis.
Methods    The effect of PC induced by low-dose LPS 
on survival rate and liver injury against subsequent high-
dose LPS stimulation was examined using a mouse 
model of sepsis. In order to understand the detailed 
mechanism(s) involved in the PC effect within the liver, 
gene expression array was performed. As a candidate 
mechanism of PC, the activation of the Nrf2 system was 
analyzed using Nrf2 reporter mice. Furthermore, the 
induction of heme oxygenase-1 (HO-1), one of the main 
targets of Nrf2, in the liver was examined by immuno-
blotting and immunohistochemistry.  The PC effect on 
liver injury induced by LPS was further examined using 
Nrf2-deficient mice.
Results    PC by LPS (1.7 or 5.0 mg/kg body weight, 
intraperitoneally) increased the survival rate of mice and 
decreased liver injury in response to a subsequent in-
jection of a lethal level of LPS (20 mg/kg body weight). 
DNA array revealed that the gene ontology term “anti-
oxidant activity” as one of the candidate mechanisms 
of the PC effect by LPS. In Nrf2 reporter mice, PC 
immediately and intensely enhanced luminescence that 
indicated Nrf2 activation after subsequent LPS injection. 
The induction of HO-1 by LPS was also enhanced by 
preceding PC, and its induction was observed mainly 
in Kupffer cells of the liver. In Nrf2-deficient mice, the 
induction of HO-1 in Kupffer cells and the hepatoprotec-
tive effect of PC were decreased as compared with wild-
type mice. 
Conclusion    Our results suggest that activation of the 
Nrf2 system is, at least in part, one of the mechanisms 
of a PC effect in the mouse liver in the case of repeated 
LPS stimulation.
Key words    heme oxygenase-1; Kupffer cells; lipopoly-
saccharide; NF-E2-related factor 2; preconditioning 
Sepsis is a complex syndrome characterized by an en-
hanced innate immune response to bacterial infection. 
Lipopolysaccharide (LPS) endotoxin within the bacteri-
al wall triggers a release of proinflammatory mediators 
from macrophages and neutrophils through a Toll-like 
receptor 4 (TLR4) signaling pathway that mediates host 
damage.1 Sepsis sometimes recurs where the second 
sepsis may differ from the first sepsis on the type of or-
gan disorder induced.2 In this regard, the first sepsis may 
modify the protective reaction of organs to the patho-
genesis of the second sepsis.
 Preconditioning (PC) is an endogenous protective 
mechanism for organs by which a sublethal stress, in-
cluding ischemia,3–5 metals,6 and inflammation,7, 8 con-
fers tolerance to a subsequent lethal stress. The detailed 
mechanisms of PC are not yet fully understood, how-
ever, experimental and clinical evidence from various 
sources, especially in the ischemic preconditioning field, 
have highlighted alterations in gene expression3–5 and 
epigenomic modifications9 as candidate mechanisms of 
the PC phenomenon. 
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 Oxidative stress contributes, at least in part, to the 
pathogenesis of LPS-induced sepsis and inflammation.10 
Therefore, reduction of oxidative stress via gene expres-
sion of antioxidative molecules may be associated with 
PC mechanisms. Nuclear factor erythroid 2 (NF-E2)-re-
lated factor-2 (Nrf2) is known as a key regulator of an 
antioxidative response.11 Nrf2 usually binds to Keap1, 
an E3 ubiquitin ligase, and is located in the extranuclear 
space of cells. Under normal conditions, Nrf2 is unstable 
because it is proteolyzed by an ubiquitin-proteasome 
system; however, once cells are exposed to oxidative 
stress, Nrf2 translocates to the nucleus and acts as a 
transcription factor. Nrf2 binds to the antioxidant re-
sponse element (ARE) and upregulates ARE-driven 
genes such as heme oxygenase-1 (HO-1).11 Indeed, LPS 
induced Nrf2-related gene expression and Nrf2-deficient 
mice are vulnerable to LPS-induced sepsis.12–17 
 In the present study, we focused on the role of Nrf2 
in PC under recurrent LPS exposure. 
MATERIALS AND METHODS
Chemicals and antibodies
LPS from Salmonella enterica serotype enteritidis was 
purchased from Sigma (St. Louis, MO). Beetle lucifer-
in for Nrf2 reporter mice was obtained from Promega 
(Madison, WI). Antibodies against HO-1 and CD163 
were obtained from Santa Cruz (Dallas, TX), and an-
ti-β-actin antibody was obtained from Cell Signaling 
Technology (Danvers, MA). Horseradish peroxidase 
(HRP)-linked anti-rabbit antibody for western blotting 
was obtained from GE Healthcare (Buckinghamshire, 
UK).
Animals
C57BL/6 mice (n = 61, male) were obtained from CLEA 
Japan (Tokyo, Japan). Nrf2-deficient mice (n = 12, male) 
and Nrf2 reporter mice (OKD48 mice)18 (n = 3, male) 
were kindly provided by Dr. Warabi (University of 
Tsukuba, Tsukuba, Japan) and Dr. Iwawaki (Gunma Uni-
versity, Maebashi, Japan), respectively. The mice were 
housed under standardized conditions of light (06:00–
18:00), temperature (25 °C), and humidity (approximately 
50%), and were allowed free access to food and water. 
The mice used in this study were treated in accordance 
with the Guidelines for Animal Experimentation of Tot-
tori University (No.14-Y-01). All surgical procedures and 
collecting blood samples were performed under deep 
anesthesia with pentobarbital, and in vivo Nrf2 reporter 
assay was carried out under inhalation anesthesia with 
isoflurane, and all efforts were made to minimize suffer-
ing.
 Experimental procedures are shown in Fig. 1. Brief-
ly, the paired administration of LPS, PC and main stim-
ulation (MS), was carried out. Firstly, 0 (vehicle), 1.7, or 
5.0 mg/kg body weight (BW) of LPS dissolved in PBS 
was administered intraperitoneally (i.p.) in C57BL/6 
mice as PC at day –5. Subsequently, after 5 days (day 
0), 0 or 20 mg/kg BW of LPS was administered i.p. to 
each PC group as the MS. Hereafter, these five groups: 
i) 0 mg/kg BW LPS as PC and 0 mg/kg BW LPS as 
MS; ii) 0 mg/kg BW LPS as PC and 20 mg/kg BW LPS 
as MS; iii) 1.7 mg/kg BW LPS as PC and 0 mg/kg BW 
LPS as MS; iv) 1.7 mg/kg BW LPS as PC and 20 mg/
kg BW LPS as MS, and v) 5.0 mg/kg BW LPS as PC 
and 20 mg/kg BW LPS as MS, were referred to as: i) 
PC0-LPS0; ii) PC0-LPS20; iii) PC1.7-LPS0; iv) PC1.7-
LPS20, and v) PC5.0-LPS20, respectively (Fig. 1A). Af-
Fig. 1. Experimental protocol performed in the present study. (A) 
PC (0, 1.7, or 5.0 mg/kg BW LPS, i.p.) was carried out at day –5 in 
C57BL/6 mice. At day 0, a high dose (20 mg/kg BW) of LPS was 
injected i.p. as a MS. Survival rates were followed for 7 days (days 
0–7). Tissue sampling for DNA array was carried out 12 h after 
MS. Western blotting (WB), histological analyses (HA), and plasma 
aminotransferase assay (ALT and AST) were carried out at days 
1, 1, and 2, respectively. Abbreviations of each condition and how 
LPS was injected are described in the figure. (B) Time course of in 
vivo Nrf2 reporter assay. Luminescence (Lumi) was detected 24 h 
after PC (on day –4) and 16 h after MS by LPS. ALT, alanine ami-
notransferase; AST, aspartate aminotransferase; BW, body weight; 
HA, histological analyses; i.p., intraperitoneal injection; LPS, lipo-
polysaccharide; Lumi, luminescence; MS, main stimulation; Nrf2, 
NF-E2-related factor-2; PC, preconditioning; WB, western blotting. 
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ter the time point shown in Fig. 1, DNA array (Fig. 1A), 
an in vivo Nrf2 reporter assay (Fig. 1B), westernblotting 
(Fig. 1A), histological analyses (Fig. 1A), and aspartate 
aminotransferase (AST)/alanine aminotransferase (ALT) 
assays in blood (Fig. 1A) were performed. Survival rates 
were followed until day 7. 
DNA microarray
Total RNAs were prepared from liver tissues using an 
SV Total RNA isolation kit (Promega). In order to ex-
amine the effect of PC with 5.0 mg/kg BW of LPS on 
the alteration of gene expression, especially in the early 
stages, RNAs were isolated from liver tissue collected 
from PC0-LPS20 mice (n = 1) and PC5.0-LPS20 mice 
(n = 1) 12 h after MS. We compared gene expression 
between PC0-LPS20 and PC5.0-LPS20 groups using 
DNA microarray (GeneChip Mouse Gene 2.0 ST array, 
Filgen, Nagoya, Japan). Using microarray data, gene on-
tology (GO) analysis (Filgen) was performed to classify 
the genes by function.
 
In vivo Nrf2 reporter assay (OKD48 mice)
In order to clarify when and where Nrf2 was activated 
in mice after LPS injection, an in vivo Nrf2 reporter as-
say was performed. For this experiment, Nrf2 reporter 
mice, known as OKD48 mice, were used. OKD48 mice 
were treated with 0, 1.7, and 5.0 mg/kg BW of LPS (i.p.) 
as PC, and after 24 h, D-luciferin (0.15 mg/kg BW) 
dissolved in PBS was administered intraperitoneally. 
Luminescence was detected using an in vivo imaging 
system IVIS (Xenogen, Alameda, CA). In a similar 
manner, Nrf2 activation in PC0-LPS20, PC1.7-LPS20, 
and PC5.0-LPS20 mice groups was examined 16 h after 
MS. 
AST and ALT assays
Blood samples (approximately 200 μL each) from PC0-
LPS20 and PC1.7-LPS20 mice were collected from the 
heart using 25G needles at day 2, and bloods were cen-
trifuged at 1,200 × g to separate plasma and blood cells. 
Using AST and ALT assay kits (Transaminase CII-test; 
Wako, Osaka, Japan), plasma AST and ALT levels were 
measured as an index of liver injury.
Western blotting
Liver tissues for immunoblot analyses were collected 
from PC0-LPS0, PC1.7-LPS0, PC0-LPS20, and PC1.7-
LPS20 groups of mice 24 h after MS. Tissues were 
lysed in SDS sample buffer (50 mM Tris–HCl, pH 6.8, 
2% SDS, 10% glycerol, 1 mM phenylmethylsulfonyl 
fluoride, and 2 mM ethylenediaminetetraacetic acid). 
Protein aliquots (20 μg) were separated on the basis of 
molecular size on 12% polyacrylamide gels, transferred 
onto polyvinylidene difluoride membranes (Hybond-P; 
GE Healthcare), and hybridized with anti-HO-1 or β-ac-
tin antibody in PBS with 0.1% Tween 20 at room tem-
perature for 1 h. The immunoreactive signal was detect-
ed using HRP-linked anti-rabbit or mouse IgG and ECL 
detection reagents (GE Healthcare). The protein content 
of each sample was measured using a bicinchonic acid 
(BCA) protein assay system (Thermo Fisher Scientific, 
Rockford, IL). 
Histological studies 
Hematoxylin-eosin (HE) staining and immunohisto-
chemistry were performed on paraffin-embedded sec-
tions of mouse liver, brain, lung, and kidney 24 after 
MS. A portion of liver tissue was fixed by perfusion 
using 4% paraformaldehyde (Wako), and embedded in 
paraffin. Paraffin sections (4 μm) were deparaffinized 
by placing slides into three changes of xylene, followed 
by rehydration in a graded ethanol series. Sections were 
treated with methanol containing 3% H2O2 at room tem-
perature for 30 min to reduce endogenous peroxidase ac-
tivity. HE staining was performed following a standard 
protocol.
 HO-1 and CD163, as a marker of Kupffer cells, were 
detected by incubating sections in HO-1 antibody at a 
1:1000 dilution or CD163 antibody at a 1:1000 dilution in 
PBS at 4 °C overnight. The labeled antigens were visual-
ized using a Histofine kit (Nichirei Biosciences, Tokyo, 
Japan), followed by followed by manufacturer’s protocol 
using HRP/3,3-Diamiobenzidine (DAB) and/or alkaline 
phosphatase/fuchsin reaction. For double staining for 
HO-1 and CD163, the signal of HO-1 was visualized by 
alkaline phosphatase/fuchsin reaction (red) and that of 
CD163 was visualized by HRP/DAB reaction (brown). 
Finally, sections were counterstained with hematoxylin 
and observed by microscopy (BZ-9000; Keyence, To-
kyo, Japan). 
Statistics
Quantitative data were assessed by ANOVA using the 
Stat View software. The criterion for statistical signifi-
cance was P < 0.05 for the AST/ALT assay All values 
are expressed as means ± S.D. Survival curves were 
compared by the use of Kaplan–Meiyer analysis and 
Log–rank test. Values of P < 0.05 were considered statis-
tically significant. P-value in GO analysis was calculated 
by two tailed Fisher’s extract test using manufacturer’s 
software (Filgen).
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RESULTS
PC by low-dose LPS gives the tolerance against 
subsequent stimulation by high-dose LPS 
We examined the effect of PC by LPS on survival rate 
after the subsequent administration of a high- dose (20 
mg/kg BW) of LPS. Although the administration of 
high-dose LPS (20 mg/kg BW) decreased the survival 
rate of mice (to approximately 12.5% after 1.5 days), PC 
using medium or low doses of LPS (5.0 or 1.7 mg/kg 
BW, respectively) improved the survival rate to 87.5 % 
and 100%, respectively (Fig. 2A).  
 In order to clarify the effect of PC by low-dose LPS 
on liver injury in response to a subsequent high dose of 
LPS, we measured plasma ALT and AST levels in mice 
2 days after MS. Although the plasma ALT level was 
significantly elevated in the PC0-LPS20 mice group, the 
ALT level in the PC1.7-LPS20 mice group was signifi-
cantly decreased compared with that of the PC0-LPS20 
group (Fig. 2B). The plasma AST level showed a similar 
pattern to the ALT level, however the difference between 
the PC0-LPS20 and PC1.7-LPS20 group was not statisti-
cally significant (Fig. 2C).  
 We performed histological analyses of liver tissues 
24 after MS (Figs. 2D–H).  In livers from the PC0-
LPS20 mice group, small areas of focal necrosis (Fig. 
2E) and infiltrating neutrophils were observed in the 
Fig. 2. PC by low-dose LPS induces tolerance 
against later high-dose LPS stimulation. (A) Life 
spans of LPS-injected mice (n = 8, each group). 
The life spans of PC1.7-LPS20 and PC5.0-LPS20 
mice groups are significantly longer than that of 
the PC0-LPS20 group. *: P < 0.01 vs. PC0-LPS20, 
**: P < 0.05 vs. PC0-LPS20. (B, C) Plasma ALT 
and AST levels in PC0-LPS0 (n = 3), PC0-LPS20 
(n = 4), and PC1.7-LPS20 groups (n = 7). *: P < 
0.05 vs. PC0-LPS0, **: P < 0.05 vs. PC0-LPS20. 
(ANOVA) (D–H) HE staining of liver tissues. (D–H) HE staining of the liver. (D) The liver from a representative PC0-LPS0 mouse. (E) 
The liver from a representative PC0-LPS20 mouse. Sites of focal necrosis are scattered within the liver (arrowheads). (F) The liver from a 
representative PC0-LPS20 mouse at higher magnification. Neutrophil infiltration is observed in the sinusoids (arrows). (G) The liver from 
a representative PC1.7-LPS20 mouse. A small area of focal necrosis (arrowhead) is observed in the liver. (H) The liver from a representa-
tive PC1.7-LPS20 mouse at higher magnification. A small number of infiltrating neutrophils is observed in a sinusoid (arrow). Scale bars 
(D)(E)(G) represent 200 μm and (F)(H) 100 μm. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CV, central vein; HE, 
hematoxylin-eosin; LPS, lipopolysaccharide; PC, preconditioning; PV, portal vein. 
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sinusoids of the liver (Fig. 2F). On the other hand, livers 
from the PC1.7-LPS20 mice group showed milder fo-
cal necrosis and cellular infiltration compared with the 
PC0-LPS20 group (Figs. 2G and H). We also investigat-
ed the effect of PC on its protective role against sepsis in 
the brain, lungs, and kidneys. Microhemorrhages in the 
cerebral cortex 7 days after MS were reduced in brains 
from PC1.7-LPS20 mice compared with those in PC0-
LPS20 mice (data not shown). In lungs from PC1.7-
LPS20 mice, the number of inflammatory cells 24 h af-
ter MS was reduced compared with that for PC0-LPS20 
mice (data not shown). In kidneys from PC1.7-LPS20 
mice, kidney tubular necrosis 7 days after MS was mild-
er than that in PC0-LPS20 mice (data not shown). 
PC by low-dose LPS enhances Nrf2 activation 
during later stimulation by high-dose LPS
In order to identify the mechanism(s) which contributed 
to a PC effect, we performed gene expression array and 
compared gene expression patterns between PC0-LPS20 
and PC5.0-LPS20 groups. GO analysis using microar-
ray data highlighted several classified genes that were 
activated by PC. We chose 5 molecular functions in GO 
terms by cutting off the line that met both a Z-score > 0 
and a P value < 0.05: antioxidant activity, binding activ-
ity, catalytic activity, electron carrier activity, and trans-
porter activity (Table 1). We then focused on “antioxidant 
activity” in GO terms, and investigated Nrf2 as a key 
regulator of antioxidant molecules.
 Using Nrf2-reporter mice (OKD48 mice), we an-
alyzed Nrf2 activation on the point of time and spatial 
elements. PC by intraperitoneal injection of 1.7 or 5.0 
mgk/g BW LPS mildly activated Nrf2 in the abdominal 
cavity; luminescence was detected 24 h after PC (Fig. 
3A; upper panel). An intraperitoneal administration of 
20 mg/kg BW LPS as a MS enhanced the activation of 
Nrf2 not only in the abdominal cavity but also in the 
lungs 16 h after MS (Fig. 3A; lower panel, right). Fur-
thermore, activation of Nrf2 in PC1.7-LPS20 and PC5.0-
LPS20 mice was more intense and more immediate than 
that in the case of a single LPS injection (shown in the 
upper panel; Fig. 3A, middle and left). 
 We next examined the induction of HO-1 protein in 
the liver by western blotting since this enzyme is one of 
the major targets of Nrf2 24 h after MS. The expression 
of HO-1 in liver from a single LPS injection of PC1.7-
LPS0 or PC0-LPS20 mice was minimal (Fig. 3B). In 
contrast, the induction of HO-1 was more intense in liver 
from PC1.7-LPS20 mice, than that from other groups, 
24 h after MS (Fig. 3B). 
 In order to confirm what type of cells express 
HO-1 in the liver, we performed immunohistochemi-
cal analyses at the same time of western blotting. The 
inducible expression of HO-1 was observed mainly in 
the CD163-positive Kupffer cells but not in hepatocytes 
in liver from PC1.7-LPS20 mice (Fig 3D). In liver from 
PC0-LPS20, the expression of HO-1 in the CD163 posi-
tive cells was faint (Fig. 3C).
Table 1 . GO terms that are upregulated in PC5.0-
LPS20 compared with PC0-LPS20
Molecular function (GO term) Z-score P-value
Antioxidant activity 2.458 0.0395
Binding 2.547 0.0003
Catalytic activity 6.788 < 0.0001
Electron carrier activity 2.668 0.0196
Transporter activity 3.084 0.0036
GO, gene ontology; LPS, lipopolysaccharide; PC, preconditioning. 
Nrf2 deficiency cancels the protective effect of PC 
on liver disturbances
We further analyzed the PC effect on liver injury using 
Nrf2-deficient mice. In these mice, the induction of 
HO-1 in livers from PC1.7-LPS20 group mice was abol-
ished 24 h after MS as compared with the PC1.7-LPS20 
wild-type mice (Fig. 4A). Immunohistochemistry also 
showed a reduced expression of HO-1 in Kupffer cells 
(Figs. 4B and C). In Nrf2-deficient mice with PC0-
LPS20 stimulation, liver tissue was severely damaged 
with microhemorrhage, and numerous neutrophils infil-
trated the liver, 24 h after MS (Fig. 4D). In contrast, the 
PC1.7-LPS20 group showed a mild improvement in his-
tological changes in the liver in terms of focal necrosis, 
microhemorrhage, and neutrophil infiltration (Figs. 4E 
and F), however, the protective effect of PC in Nrf2-de-
ficient mice (Figs. 4E and F) was weaker than what was 
seen in wild-type mice (Figs. 2G and H).  
DISCUSSION
Recently, increased attention has been given to the 
protective effect of PC against adverse effects such as 
sublethal ischemia, exposure to mild toxin, and inflam-
mation.3–8 Numerous reports suggest that PC prevents 
severe organ damage induced by later, more deleterious 
events.3–8 
 Sepsis is a syndrome characterized by an enhanced 
innate immune response to bacterial infection. LPS 
usually triggers a release of proinflammatory mediators, 
such as interleukins and nitric oxide, from macrophages 
and neutrophils through a TLR4/NF-κB signaling path-
way that mediates host damage.1 Sepsis often occurs 
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repeatedly, with a second sepsis that may differ from the 
fi rst sepsis in terms of organ disturbance.2 For example, 
organs may sometimes gain a tolerance against sepsis 
when exposed to an initial, LPS-induced sepsis, which 
prevents severe organ disorders on the occurrence of 
a second sepsis.2, 7, 8 Such a phenomenon, whereby a 
tolerance is gained by a preceding mild load, has been 
termed PC. Several PC phenomena have been report-
ed in various organs and animal species.3–8 Ischemia 
and ischemia–reperfusion are the most investigated PC 
events to confer tolerance against later, more severe 
ischemia.3–5 Research on a PC effect by ischemia or 
ischemia–reperfusion may be useful for understanding 
underlying mechanisms in cases of organ transplantation 
in various clinical stages. In a similar manner, research 
on a PC effect by low-dose LPS may also be useful for 
understanding how to prevent severe organ damage in 
repeated sepsis. 
 It is well known that Nrf2 and antioxidant molecules 
are upregulated by single LPS stimulation, however, 
it has not been clarifi ed whether Nrf2 and antioxidant 
molecules are also associated with PC effects by low 
dose LPS.12–17 In order to clarify which molecular 
mechanism(s) was associated with such a PC effect, we 
performed DNA microarray and compared gene ex-
pression between PC0-LPS20 and PC5.0-LPS20 treated 
mice. Since the microarray highlighted the induction 
of genes associated with antioxidant activity as a point 
of difference between the two mice groups examined, 
we hypothesized that increased antioxidant activity was 
one of the candidate mechanisms whereby PC induced 
a protective effect in the liver. Oxidative stress is one of 
the most important factors in the pathogenesis of sep-
sis.10 Therefore, we focused on Nrf2, a key transcription 
factor for the induction of endogenous antioxidant mol-
ecules under oxidative stress,11 as one of the candidate 
targets for PC mechanisms. DNA array revealed an 
induction of HO-1 in PC5.0-LPS20 mice (more than two 
Figure	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  h	  a-er	  PC	





Fig. 3. PC by low-dose LPS enhances Nrf2 activation during subsequent stimulation by high-dose LPS. (A) An in vivo Nrf2 reporter as-
say using OKD48 mice. The upper photograph shows luminescence 24 h after PC (day –4). The lower photograph shows luminescence 
16 h after MS with LPS (20 mg/kg BW). An immediate and intense luminescence is observed in PC1.7-LPS20 and PC5.0-LPS20 mice. (B) 
The induction of HO-1 protein is shown. Immunoblots are representative of three independent experiments. HO-1 protein bands in liver 
samples from PC0-LPS0, PC1.7-LPS0, and PC0-LPS20 mice appear faint. The induced expression of HO-1 protein in liver from PC1.7-
LPS20 mice is intense. (C, D) Immunohistochemistry using anti-HO-1 and anti-CD163 antibodies in the liver from PC0-LPS20 (C) and 
PC1.7-LPS20 mice (D). The expression of HO-1 (brown) is observed mainly in CD163-positive Kupffer cells. Small window in (D) rep-
resents a double staining for HO-1 (red) and CD163 (brown). Scale bars represent 100 μm. BW, body weight; HO-1, heme oxygenase-1; 
LPS, lipopolysaccharide; MS, main stimulation; Nrf2, NF-E2-related factor-2; PC, preconditioning. 
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times vs. PC0-LPS20). Therefore, we used the induction 
of HO-1 as an index of the activation of Nrf2. 
 In the present study, we demonstrated the enhanced 
activation of Nrf2 by PC with low-dose LPS adminis-
tration in vivo using Nrf2 reporter mice (Fig. 3A). An 
in vivo Nrf2 reporter assay using OKD48 mice showed 
that an intense and immediate activation of Nrf2 was 
observed throughout the whole body, including in the 
lungs and liver, in PC1.7-LPS20 or PC5.0-LPS20 mice. 
This suggests that PC by low-dose LPS induced the en-
hanced activation of Nrf2 when mice were exposed to 
severe LPS-induced toxicity after 5 days. Indeed, HO-1, 
one of the major targets of Nrf2, was dramatically in-
duced in the PC1.7-LPS20 mouse liver. Furthermore, we 
also demonstrated that an enhanced induction of HO-1 
was observed, predominantly in Kupffer cells, but not in 
hepatocytes or neutrophils 24 h after MS by LPS. This 
suggests that Kupffer cells may play an important role in 
the PC effect via an Nrf2 system.
 Kupffer cells are the resident macrophages of the 
liver. These cells are located in sinusoidal spaces and are 
in contact with portal blood draining the intestinal tract, 
during which they are exposed to bacteria and bacterial 
products such as LPS.19 Kupffer cells play an important 
role in clearing LPS.20 Moreover, the activation and in-
duction of Nrf2/HO-1 in Kupffer cells and hepatocytes 
is important for hepatoprotection against LPS-induced 
toxicity.21 Previous reports and our present studies sug-
gest that PC by low-dose LPS enhances Nrf2 activation 
and prevents severe damage of the liver.
 The Nrf2/Keap1 system is the primary sensor in the 
cellular response to oxidative stress. The cytoplasmic 
protein and ubiquitin E3 ligase, Keap1, interacts with 
Nrf2 and continuously leads it to an ubiquitin–protea-
some-dependent proteolysis.11 However, once cells are 
exposed to oxidative stress, signals associated with this 
process disrupt binding between Nrf2 and Keap1, result-
ing in the transcription of Nrf2 in the nucleus. Within 










Fig. 4. Nrf2 defi ciency abolished the protective effect of PC against liver damage by high-dose LPS in mice. (A) Immunoblot using an-
ti-HO-1 antibody. The immunoblot shown is representative of three independent experiments. In Nrf2-defi cient mice, the expression of 
HO-1 protein bands in liver samples from PC0-LPS0, PC1.7-LPS0, and PC0-LPS20 mice are faint, unlike the case for wild-type mice (far 
left lane). Liver samples from PC1.7-LPS20 treated Nrf2-defi cient mice show a lower induction of HO-1 protein (far right lane) than PC1.7-
LPS20 treated wild-type mice (far left lane). (B, C) Immunohistochemistry using anti-HO-1 antibody at the same time of western blotting. 
(B) The liver from the Nrf2-defi cient mice with PC0-LPS20, (C) The liver from the Nrf2-defi cient mice with PC1.7-LPS20. In Nrf2-defi -
cient mice, the induction of HO-1 in Kupffer cells is reduced even if samples are from PC1.7-LPS20 treatment group. (D–F) HE staining 
of the liver from Nrf2-defi cient mice. (D) The liver from Nrf2-defi cient mice with PC0-LPS20 treatment shows severe necrosis in a large 
area (arrowheads), severe neutrophil infi ltration (arrows), and microhemorrhage (white arrowhead). (E, F) In a liver from an Nrf2-defi cient 
mouse after PC1.7-LPS20 treatment, the protective effect of PC is abolished, and focal necrosis (arrowheads), neurotrophil infi ltration in 
sinusoids (arrows), and microhemorrhage (white arrowhead) are observed. Scale bars (D)(E) represent 200 μm and (B, C, F) 100 μm. CV, 
central vein; HE, hematoxylin-eosin; LPS, lipopolysaccharide; MS, main stimulation; Nrf2, NF-E2-related factor-2; PC, preconditioning. 
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the nucleus, Nrf2 forms a heterodimer with a small-
Maf protein and activates the transcription of oxidative 
stress-related genes via an ARE.11 Recently, PC by mild 
ischemia in the brain was found to confer tolerance 
against later severe ischemic events via epigenomic 
modification on the promotor area of the Nrf2 gene.9 
Moreover, evidence suggests that Nrf2 and its related 
systems are controlled by epigenomic modifications fol-
lowing several conditions.22, 23 These facts suggest that 
an epigenomic change of the Nrf2 gene may also be in-
cluded in an LPS-induced PC phenomenon.  Intense and 
immediate upregulation of Nrf2 by PC may bring the 
resistance against oxidative stress. Furthermore, it has 
been reported recently that Nrf2 suppresses macrophage 
inflammatory response by blocking proinflammatory 
cytokine transcription.24 These facts suggest that PC ef-
fect against LPS-induced injury in our experiments may 
include not only antioxidant activity but also suppression 
of cytokine transcription. 
 In order to confirm the role of Nrf2 on the protec-
tive effect of PC, we examined this using Nrf2-deficient 
mice. A severe vulnerability against a preceding stim-
ulation by LPS was noted in Nrf2-deficient mice, with 
more than a half of the mice dying after a single stimu-
lation for PC (data not shown). Therefore, we could not 
compare survival rates of PC0-LPS20, PC1.7-LPS20, 
and PC5.0-LPS20 groups after MS. Since we used tissue 
samples from the limited numbers of mice that survived 
during our experimental procedures, we should consider 
that other mechanisms for tolerance may have been en-
hanced in the surviving Nrf2-deficient mice.  
 The decreased induction of HO-1 (Fig. 4A), and 
increased focal necrosis (Fig. 4E) and neutrophil infil-
tration (Fig. 4F) in the liver were observed in surviving 
Nrf2-deficient mice, even in the PC group as cpmpared 
with wild-type mice. These results strongly suggest that 
Nrf2 plays an important role in hepatoprotection during 
PC and subsequent LPS stimulation.  Even in Nrf2-defi-
cient mice, a mild induction of HO-1 was still observed 
in Kupffer cells (Fig. 4C). Since the expression of HO-1 
is also controlled by other transcription factors such as 
AP-1 in addition to Nrf2,25 this may explain why HO-1 
continued to be induced in the liver by LPS in Nrf2-de-
ficient mice. 
 Our results suggest that Nrf2 plays key role in the 
hepatoprotective effect induced by PC with low-dose 
LPS, however, the detailed mechanism of how Nrf2 is 
enhanced by PC remains unknown. Therefore, further 
studies, such as on the epigenomic modifications of the 
Nrf2 gene, are required in future.  
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